Literature DB >> 16122702

ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin.

Weiguo Zou1, Vladimir Papov, Oxana Malakhova, Keun Il Kim, Chinh Dao, Jun Li, Dong-Er Zhang.   

Abstract

ISG15 was the first ubiquitin-like modifier to be identified. However, the function of ISG15 modification has been an enigma for many years. At present, no data are available about the function of ISGylation for any target. In this paper, we report the identification of Ubc13, which forms a unique ubiquitin-conjugating enzyme (Ubc) complex with ubiquitin enzyme variant Mms2 and generates atypical Lys63-linked ubiquitin conjugates, as one of the targets of ISG15 modification. Furthermore, we identify Lys92 as the only ISG15 modification site in Ubc13, which is the first report about the ISG15 modification site. Using the "covalent affinity" purification assay, we found that unmodified Ubc13 can bind to the ubiquitin-agarose, whereas ISGylated Ubc13 cannot. This result indicates that ISGylation of Ubc13 disrupts its ability to form thioester bond with ubiquitin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122702     DOI: 10.1016/j.bbrc.2005.08.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  Negative regulation of ISG15 E3 ligase EFP through its autoISGylation.

Authors:  Weiguo Zou; Ji Wang; Dong-Er Zhang
Journal:  Biochem Biophys Res Commun       Date:  2007-01-08       Impact factor: 3.575

2.  ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP.

Authors:  Fumihiko Okumura; Weiguo Zou; Dong-Er Zhang
Journal:  Genes Dev       Date:  2007-02-01       Impact factor: 11.361

Review 3.  Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.

Authors:  Ian F Pitha-Rowe; Paula M Pitha
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-03       Impact factor: 7.638

4.  ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection.

Authors:  Benedito Eduardo-Correia; Carles Martínez-Romero; Adolfo García-Sastre; Susana Guerra
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 5.  Emerging roles for immunomodulatory functions of free ISG15.

Authors:  Jessica A Campbell; Deborah J Lenschow
Journal:  J Interferon Cytokine Res       Date:  2013-09-06       Impact factor: 2.607

6.  Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15.

Authors:  Zhizhou Kuang; Eun Joo Seo; Jonathan Leis
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 7.  Identification and Validation of ISG15 Target Proteins.

Authors:  Larissa A Durfee; Jon M Huibregtse
Journal:  Subcell Biochem       Date:  2010

8.  The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Authors:  Johanna Bialas; Annika N Boehm; Nicola Catone; Annette Aichem; Marcus Groettrup
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

9.  The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15.

Authors:  Larissa A Durfee; Nancy Lyon; Kyungwoon Seo; Jon M Huibregtse
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

Review 10.  Antiviral activity of innate immune protein ISG15.

Authors:  Ronald N Harty; Paula M Pitha; Atsushi Okumura
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.